A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2001
11/29/2001	DE10057913A1 Blutdrucksenkende und blutdruckerhöhende Aktivitäten aus dem Nierenmark Antihypertensive and hypertensive activity from the renal medulla
11/29/2001	DE10026182A1 Colostrum product comprising immunostimulant, wound healing, antibacterial, antiviral or antimycotic action, comprises algae, Indian gooseberries and/or acerola cherries
11/29/2001	DE10024384A1 Herstellung von dendritischen Zellen aus Rückenmarkstammzellen Preparation of dendritic cells from spinal cord stem cells
11/29/2001	DE10024383A1 Mit toxischen Substanzen beladene dendritische Zellen With toxic substances loaded dendritic cells
11/29/2001	CA2808215A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001	CA2413326A1 Use of baculovirus vectors in gene therapy
11/29/2001	CA2410350A1 Use of lactobacillus casei in immunostimulatory compounds
11/29/2001	CA2410293A1 Three-layer parenteral preparations
11/29/2001	CA2410094A1 Compositions and methods for modulating tumor specific expression
11/29/2001	CA2409994A1 Apoptotic entities for use in treatment of endothelium dysfunction disorders
11/29/2001	CA2409992A1 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
11/29/2001	CA2409965A1 Fructosyltransferases (inulosucrase and levansucrase) from lactobacillus reuteri
11/29/2001	CA2409960A1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/29/2001	CA2409772A1 Antiviral therapy
11/29/2001	CA2409299A1 Compositions and methods for the therapy and diagnosis of breast cancer
11/28/2001	EP1157702A1 Compositions comprising DNA Damaging Agents and p53
11/28/2001	EP1157699A1 Blood pressure lowering and elevating activities obtained from kidney medulla
11/28/2001	EP1157696A2 Treatment of rumen acidosis with alpha-amylase inhibitors
11/28/2001	EP1157122A1 Anti-neoplastic compositions and uses thereof
11/28/2001	EP1157094A2 Method for the purification, recovery, and sporulation of cysts and oocysts
11/28/2001	EP1156820A1 Vascular endothelial growth factor-2
11/28/2001	EP1156813A2 Reovirus for the treatment of cellular proliferative disorders
11/28/2001	EP1023085A4 Human embryonic germ cell line and methods of use
11/28/2001	EP1007183A4 Blood processing chamber counter-balanced with blood-free liquid
11/28/2001	EP0845032B1 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
11/28/2001	EP0789588A4 Method for making a medicament for treating secondary immunodeficiency
11/28/2001	EP0698108B1 Adenoviral vectors of animal origin and use thereof in gene therapy
11/28/2001	EP0692966B1 A process for separation of components from red blood cells
11/28/2001	CN1324406A DNA molecules encoding MUC-1 and use thereof in tumor vaccination
11/28/2001	CN1324400A Method of screening for large offspring syndrome
11/28/2001	CN1324394A Method for extracting lipid from marine and aquatic animal tissues
11/28/2001	CN1324254A Dermal scaffold comprising nutralized chitosan sponge, nutralized chitosan/collagen mixed sponge
11/28/2001	CN1324251A Method of stimulating prosaposin receptor activity
11/28/2001	CN1324245A Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents
11/28/2001	CN1324212A Method for treating or preventing viral infections and associated diseases
11/28/2001	CN1323631A Paralysis treating medicine bolus
11/28/2001	CN1323629A Hyperosteogeny treating plaster
11/28/2001	CN1323624A Xueduqing capsule, oral liquid and mask for eliminating blood toxin
11/28/2001	CN1323622A Rheumatism treating traditional Chinese medicine prepn. and its prepn. process
11/28/2001	CN1323612A Mihaigao ointment made of honey, sepium and other traditional Chinese medicine and its prepn.
11/28/2001	CN1323608A Xinnaotong capsule for treating blood vessel of heart and brain
11/28/2001	CN1323607A Fast-acting heart disease curing drop pill
11/28/2001	CN1323602A Piles treating medicine and its prepn.
11/28/2001	CN1323600A Compound cassia seed eye drops
11/28/2001	CN1323599A Medicine for treating diseases of digestive system
11/28/2001	CN1323587A Formulation and production process of royal jelly capsule
11/28/2001	CN1323586A Formulation and production process of bee glue capsule
11/28/2001	CN1323585A Formulation and production process of melissa powder capsule
11/28/2001	CN1323580A Health giving bathing mud
11/28/2001	CN1075384C Chinese medicine preparation for treating acne
11/28/2001	CN1075380C Medicine for enuresis
11/28/2001	CN1075374C Heme antianemia medicine and preparation method
11/27/2001	US6322804 Implantable biocompatible immunoisolatory vehicle for the delivery of selected therapeutic products
11/27/2001	US6322795 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
11/27/2001	US6322790 Treatment of primary and metastatic noeplastic diseases and infectious diseases; administering antigen presenting cells sensitized with complexes of hsps noncovalently bound to an antigenic molecule
11/27/2001	US6322787 Induction of an anti-tumor immunity by redirecting tumor cells against antigen-presenting cells
11/27/2001	US6322785 Platelet-rich-plasma activated by calcium chloride solution, and an aqueous suspension of partially frayed type i collagen
11/27/2001	US6322784 Glucocorticoid, a compound which stimulates camp production and compound which upregulates peroxisome proliferator activated receptor .gamma. expression
11/27/2001	US6322783 Bacteriophages, method for screening same and bactericidal compositions using same, and detection kits using same
11/27/2001	CA2083286C Recombinant fibrinogenases, preparation and use thereof
11/27/2001	CA2080693C Composite living skin equivalents
11/25/2001	CA2309518A1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/25/2001	CA2309424A1 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
11/25/2001	CA2309417A1 Apoptotic entities for use in treatment of endothelium dysfunction disorders
11/24/2001	CA2309235A1 Fusion polypeptides
11/22/2001	WO2001088128A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	WO2001088116A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
11/22/2001	WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001	WO2001088106A2 Novel deoxyribonucleside kinase enzyme multi-substrate variants
11/22/2001	WO2001088105A2 Production of dendritic cells from bone-marrow stem cells
11/22/2001	WO2001088104A2 Neural progenitor cell populations
11/22/2001	WO2001088103A2 Compositions and methods for tissue dedifferentiation and regeneration
11/22/2001	WO2001088102A1 Method for preventing allograft rejection
11/22/2001	WO2001088099A1 Cells, culture methods and their uses
11/22/2001	WO2001088098A2 Fertilization of aged oocytes
11/22/2001	WO2001088097A1 Immune potentiating compositions
11/22/2001	WO2001088096A2 Ovine tissue for xenotransplantation
11/22/2001	WO2001088095A1 Microorganisms for treatment or prevention of obesity and diabetes mellitus, and pharmaceutical composition containing the same
11/22/2001	WO2001087935A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
11/22/2001	WO2001087934A2 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides
11/22/2001	WO2001087923A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001	WO2001087895A1 Synthetic process for the manufacture of an ecteinaschidin compound
11/22/2001	WO2001087894A1 Antitumoral analogs of et-743
11/22/2001	WO2001087350A2 Treatment of human papillomavirus (hpv)-infected cells
11/22/2001	WO2001087346A2 Dendritic cells loaded with toxic substances
11/22/2001	WO2001087325A1 Method to increase class i presentation of exogenous antigens by human dendritic cells
11/22/2001	WO2001087316A2 Composition and method for increasing testosterone levels
11/22/2001	WO2001087314A1 Methods and compositions for promoting angiogenesis using monocytes
11/22/2001	WO2001087273A1 Delivery mechanism for the introduction of biological substances to animals
11/22/2001	WO2001087192A1 Tissue engineered stents
11/22/2001	WO2001087071A1 Methods for enriching for quiescent cells in hematopoietic cell populations
11/22/2001	WO2001087039A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
11/22/2001	WO2001087037A1 Methods for modulating the proliferation of hematopoietic cells
11/22/2001	WO2001036650A3 An oncolytic adenovirus
11/22/2001	WO2001036476A3 Ing2, an iaps associated cell cycle protein, compositions and methods of use
11/22/2001	WO2001031036A3 Modified viral surface proteins which bind to cells of tumor vasculature
11/22/2001	WO2001019380A3 Oncolytic virus
11/22/2001	WO2001018169A3 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases
11/22/2001	WO2001007637B1 Conditionally controlled, attenuated hiv vaccine
11/22/2001	WO2000070022A9 Ex vivo expansion of mammalian hematopoietic stem cells

1 ... 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 ... 1259